DESMOPRESSINE SANDOZ 120 micrograms, sublingual tablet 30 tablets
Active ingredients: Desmopressin acetate, Desmopressin
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tabletssublinguale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DESMOPRESSINE SANDOZ 120 microgrammes, comprimé sublingual
- Pharmaceutical form
- comprimé
- Route of administration
- sublinguale
- Presentation description
- plaquette(s) OPA : polyamide orienté aluminium PVC polyéthylène de 30 comprimé(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 May 2025
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68095745CIP73027552CIP133400930275528Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DESMOPRESSINEcomprimé | 120 microgrammes · un comprimé | FT |
| ACÉTATE DE DESMOPRESSINEcomprimé | 133 microgrammes · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.